Effects of Once-Weekly Teriparatide Treatment on Trabecular Bone Microdamage Accumulation and Cortical Structure in the Lumbar Vertebrae of Ovariectomized Cynomolgus Monkeys-Reference-Cited by-同舟云学术

Effects of Once-Weekly Teriparatide Treatment on Trabecular Bone Microdamage Accumulation and Cortical Structure in the Lumbar Vertebrae of Ovariectomized Cynomolgus Monkeys

Published:2021-12-01 Issue: Volume: Page:361-376
ISSN:
Container-title:Osteoporotic Fracture and Systemic Skeletal Disorders
language:
Short-container-title:

Author:

Mashiba Tasuku,Fujihara Ryuji,Yoshitake Shingo,Iwata Ken,Takao-Kawabata Ryoko,Yamamoto Tetsuji

Publisher

Springer Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-16-5613-2_23

Reference43 articles.

1. Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists and American college of endocrinology clinical practice guideline for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract. 2016;22:1–42.

2. Recker RR, Bare SP, Smith SY, et al. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84. Bone. 2009;44:113–9.

3. Jiang Y, Zhao JJ, Mitlak BH, et al. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18:1932–41.

4. Dobnig H, Stepan JJ, Burr DB, et al. Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate. J Bone Miner Res. 2009;24:1998–2006.

5. Saito M, Marumo K, Kida Y, et al. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int. 2011;22:2373–83.